Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.
Clinical Research Studies of Atimociclib in HR+/HER2- and/or HER2+ Breast Cancer supports investigators studying atimociclib combinations to generate clinical evidence for breast cancer treatment.
Implementation of an Integrated Precision Care Pathway Program for Metastatic Prostate Cancer supports healthcare teams' quality improvement work to improve testing and coordinated care in Mainland China.
Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.
Bayer funds educational programs advancing knowledge of new therapies, treatment strategies, and quality of life in advanced prostate cancer.
Improving Quality of Care and Scalable Implementation of Bispecific Antibody Therapy in Multiple Myeloma supports healthcare teams’ quality improvement projects to standardize myeloma care in Germany.